This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Therapeutic use of epigenetic modulators in oncological and neurodegenerative diseases Investments < €500k Germany 2016
Depletion of interfering antibodies for biomarker-based monitoring of clinical trials for immunotherapy of Alzheimer’s disease Investments < €500k Germany 2016
Design, synthesis and pharmacological evaluation of Multi-Target Directed Ligands as potential procognitive drugs in Alzheimer’s disease treatment Investments < €500k France 2016
Dynamic combinatorial synthesis of optical molecular markers of the aggregated Aβ peptide Investments < €500k France 2016
A novel APP processing pathway and its physiological function in modulation of synaptic activity Investments < €500k France 2016
Contributions of amino- and dipeptidyl-peptidases-mediated truncations of amyloid peptides to Alzheimer’s disease: a combined cellular and in vivo approach Investments < €500k France 2016
Impairment of Synaptic Vesicles function in Alzheimer Disease Investments < €500k France 2016
Human iPSCs-derived neuron-astrocyte co-culture as an innovative strategy to study the role of astrocytes in Alzheimer’s disease Investments < €500k France 2016
Role of astrocytic 3-phosphoglycerate dehydrogenase in AD Investments < €500k France 2016
Biological and mathematical modelization of amyloid origin, spreading and impact on brain function Investments < €500k France 2016
